Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

3D Bioprinting Market Research Report Information By Technology (Microextrusion Bioprinting, Inkjet 3D Bioprinting, Laser-assisted Bioprinting, Magnetic 3D Bioprinting), By Material (Living Cells, Hydrogels, And Extracellular Matrices), By Application (Research Applications, And Clinical Applications), By End Users (Pharmaceutical & Biotechnology Companies, Research and Organizations & Academic Institutes), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032

ID: MRFR/MED/0367-CR | 163 Pages | Author: Kinjoll Dey| February 2021

Global 3D Bioprinting Market Overview

The 3D bioprinting market size was valued at USD 2.49 billion in 2023 and is projected to grow from USD 2.87 Billion in 2024 to USD 9.41 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 15.98% during the forecast period (2024 - 2032). The main market drivers boosting market growth are the lack of organ donors and the aging population with chronic respiratory illnesses.

3D Bioprinting Market

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

April 2024: HP Inc.and INDO-MIM, a US- and India-based provider of metal injection molding (MIM) powders and contract manufacturer, have disclosed that the two organizations will partner to boost additive manufacturing (AM) of end-use metal parts in India. In its India and Texas operations, INDO-MIM asserts to have the world's biggest installed capacity for MIM production. HP and INDO-MIM first disclosed a deliberate collaboration ahead of Formnext 2023 as a fraction of a flurry of announcements surrounding HP's Metal Jet S100 metal binder jetting (MBJ) system. The update on the brand's joint activities, disclosed at a press briefing in Bengaluru, announced that INDO-MIM has bought three Metal Jet S100 machines so far, with two of them operational at INDO-MIM's Bengaluru facility, and the third installed at INDO-MIM's Texas site. As per the INDO-MIM, one of the printers in Bengaluru will be utilized for material development, while the other will be employed to explore applications for customers in the Asia-Pacific region, particularly in the Middle East and India. The organization didn't clearly know what the Texas machine would be utilized for, but having it on the ground in the US would certainly allow INDO-MIM to explore the Metal Jet S100's potential for distributed manufacturing.
September 2023: As per the latest USD 26.3 million federal agreement from the Advanced Research Projects Agency for Health (ARPA-H), a multidisciplinary squad of researchers at Stanford University focuses on bioprinting a completely functioning human heart and implanting it in a living pig within five years. The assistant professor of bioengineering in the Schools of Engineering and Medicine, Mark Skylar-Scott, said that it's truly a moonshot effort. Still, the raw ingredients for bioprinting a full and complex human organ are now in place for this big push.

3D Bioprinting Market Trends

  • Growing high demand for transplantable tissues and organs to boost market growth

Globally, there is a massive demand for vital body parts for transplantation. Even worse, there is a significant discrepancy between the supply and demand of organs and tissues. The heart, kidneys, lungs, liver, pancreas, and intestines are just a few organs required for transplantation.

Similarly, there is a tremendous demand for bone, skin, blood vessels, heart valves, and cornea transplants. Although there is a growing need for organs and tissues, organ donation rates remain the same. The increasing number of patients on the transplant waiting list as a result of the unavailability of these parts for transplantation is a significant problem for healthcare organizations and providers. Since researchers are utilizing new technologies for safety testing in patients after preclinical trials are finished, the coronavirus pandemic has also sped up the development of medicine and vaccine testing. The medical community is also experiencing a respirator and ventilator shortage due to the rising number of COVID-19 cases. To address the lack of this equipment, 3D bioprinting technology assists in producing respirators and ventilators. Companies across the world are soaring high on innovation and creativity that will help in coming up with regenerative medicine along with their concept solutions related to tissue engineering, stem cell therapies, alongside drug therapies.

A respiratory epithelium model was recently produced by the 3D bioprinting business CLECELL combining existing bioprinting technologies and their 3D printer, the U-FAB. A type of tissue called respiratory epithelium lines most of the respiratory tract. This epithelium blocks pathogens and foreign substances. Consequently, the market for 3D bioprinting will be expected to expand due to rising demand for this respiratory epithelium model. Therefore, the condition has recently enhanced the 3D Bioprinting market CAGR globally.

However, the growth of public and private funding for research efforts in bioprinting is another factor driving the market revenue of the 3D Bioprinting.

3D Bioprinting Market Segment Insights

3D Bioprinting Insights

Based on technology, the market segments of 3D Bioprinting includes micro extrusion bioprinting, inkjet 3D bioprinting, laser-assisted bioprinting, and magnetic 3D bioprinting. The Inkjet 3D Bioprinting segment held the majority share in 2022, contributing to around ~40% of the 3D Bioprinting market revenue. One of the driving forces behind the development of this market is the extensive usage of inkjet printing in the healthcare sector. This study specifically addresses the issues of biochemical regeneration, medication delivery costs, and inkjet printing as a bio-applicable technique. This market segment is anticipated to expand significantly due to its increased durability and rising demand.

3D Bioprinting Insights

Based on Material, the global 3D Bioprinting market segmentation includes living cells, hydrogels, and extracellular matrices. The Living Cells segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period, 2024-2032. because investments in stem cells and regenerative medicine are rising along with the utilization of living cells in these fields. For instance, thanks to the technology platform developed by 3DBio Therapeutics, a startup company started by a Cornellian; people have received 3D- bio-printed ear implants made from patients' live cells in a first-of-its-kind clinical investigation. Hence, rising applications of Living Cells material implants for 3D bioprinting positively impact market growth.

3D Bioprinting Application Insights

The market data of 3D Bioprinting has been bifurcated by application into research applications and clinical applications. The clinical applications segment dominated the market in 2022 and is projected to be the faster-growing segment during the forecast period, 2024-2032. Skin, bone and cartilage, blood vessels, and other clinical applications make up the clinical applications sector. Throughout the forecast period, the clinical applications segment is anticipated to dominate the global market regarding revenue share. Creating skin tissues that are not only directly implantable but also capable of stimulating skin regeneration and scar reduction in trauma care has been the focus of research into a novel, portable 3D bioprinting process.

Figure 2: 3D Bioprinting Market, by Application, 2022 & 2032 (USD billion)3D Bioprinting Market, by Application, 2022 & 2032 (USD billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Research applications were the fastest-growing segment due to the increasing successes of scholars and business players. Bioprinting can, for instance, reproduce a complicated cancer microenvironment by precisely arranging numerous cell types and even microcapillaries. This approach develops new methods for producing prescription drugs by assisting researchers in understanding the growth and spread of cancer.

3D Bioprinting End User Insights

Based on End Users, the global 3D Bioprinting industry has been segmented into Pharmaceutical & and biotechnology companies, Research Organizations & Academic Institutes. Research Organizations & Academic Institutes held the most significant segment share in 2022; this is because stem cell research is moving forward quickly, expenditures are expanding to speed up Research & Development (R&D) efforts, and demand for regenerative medicine is rising as a result of the high frequency of chronic diseases.

The third fastest-growing segment in the 3D Bioprinting industry is pharmaceutical & biotechnology companies. Due to patients' increased reliance on technology, the development of tailored medicines, and the creation of bio-drugs using 3D bioprinting technology. For instance, Poietis and Servier, a pharmaceutical company, worked together to develop a 4D bioprinted liver model that was also better than current methods at predicting medication and liver damage.

3D Bioprinting Regional Insights

The analysis offers market insights for North America, Europe, Asia-Pacific, and the rest of the world, by region. The market for 3D bioprinting in North America reached USD 0.87 billion in 2022 and is anticipated to increase at a substantial CAGR throughout the research period. Throughout the projection period, the market would rise due to the growing adoption of IT in the healthcare sector. Around 23,369,732 active COVID-19 cases were registered in the United States alone up until January 13th, 2021, according to the Worldometer Report 2021. Over 50 vaccine candidates are now being tested. The government is investing more in research and development to produce a vaccination for this illnessa.

Further, the major countries studied in the market report are: The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 3: 3D Bioprinting Market Share By Region 2022 (%)3D BIOPRINTING MARKET SHARE BY REGION 2022 (%)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe's 3D Bioprinting market accounts for the second-largest market share due to increasing R&D activities, growing demand for organ transplants, and increasing initiatives by market players to expand their presence in this region. Further, the German market of 3D Bioprinting held the largest market share, and the UK market of 3D Bioprinting was the fastest-growing market in the European region.

The Asia-Pacific market of 3D Bioprinting is expected to grow at the fastest CAGR from 2024 to 2032. due to the size of its consumer base, the growth of this field's R&D, government backing, and tax advantages. Significant developments in this field have been achieved by Chinese researchers, including the liquid-in-liquid printing technique, which combines liquid polymers to create a stable membrane. They claim that the resulting fluid structures can hold their shape for up to 10 days before merging. Moreover, China's market of 3D Bioprinting had the largest market share, and India's 3D Bioprinting market was the fastest-growing market in the Asia-Pacific region.

3D Bioprinting Key Market Players & Competitive Insights

Major industry companies are investing a lot of money in R&D to expand their product offerings, which will spur further market growth in the 3D bioprinting. With key developments changes like new product releases, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations, market participants are also undertaking various strategic activities to expand their global presence. To grow and thrive in an environment where competition is fierce, and the market is growing, competitors in the 3D bioprinting industry must provide affordable products.

Manufacturing locally to cut operational costs is one of the leading business tactics used by manufacturers in the worldwide 3D Bioprinting industry to benefit customers and grow the market sector.In recent years, 3D Bioprinting industry has provided medicine with some of the most significant benefits. The 3D Bioprinting market major player such as EnvisionTEC, CELLINK and Others are working to expand the market demand by investing in research and development activities.

Using seven different process technologies, the privately held business EnvisionTEC creates, produces, and distributes more than 40 variants of desktop and commercial 3D printers that create items from digital design files. In September 2021, To minimize entry barriers for businesses wishing to embrace 3D printing for making molds for low volumes and more commercially, EnvisionTEC and Covestro announced their partnership on material+printer solutions.

Also, A bioconvergence firm called Bico Group creates and offers tools and services to advance biological research.  In August 2022, Indian Institute of Science (IISC) and CELLINK, a world leader in 3D bioprinter development, announced their collaboration to build a 3D bioprinting Center of Excellence in Bengaluru, India. Researchers will have access to 3D bioprinting systems through the Centre of Excellence (CoE), housed in the Centre for BioSystems Science and Engineering (BSSE) at IISc. This will enable them to advance their projects through targeted applications to enhance medical outcomes.

Key Companies in the 3D Bioprinting market includes

  • Organovo Holdings, Inc. (US)

  • ROKIT Healthcare (South Korea)

  • Cyfuse Biomedical K.K. (Japan)

  • CELLINK (Sweden)

  • EnvisionTEC GmbH (Germany)

  • Allevi Inc. (US)

  • Aspect Biosystems Ltd. (Canada)), among Others

3D Bioprinting Industry Developments

November 2023: Stratasys (Israel) introduced the F3300 Fused Deposition Modelling (FDM) 3D printing technology. The F3300 product will be more cost-effective than current Stratasys FDM solutions, with faster extrusion, autocalibration, and gantry speeds.

August 2023: Cellink (Sweden) unveiled the Bio X3 bioprinter, a multipurpose bioprinter that can print a variety of materials, such as cells, hydrogels, and biomolecules. Cellink's Bio X is a multipurpose, standalone 3D bioprinter with three replaceable printheads that may be used with a variety of bioinks and biomaterials.

3D Bioprinting Market Segmentation

3D Bioprinting Outlook

  • Microextrusion Bioprinting

  • Inkjet 3D Bioprinting

  • Laser-assisted Bioprinting

  • Magnetic 3D Bioprinting

3D Bioprinting Outlook

  • Living Cells

  • Hydrogels

  • Extracellular Matrices

3D Bioprinting Application Outlook

  • Research Applications

  • Clinical Applications

3D Bioprinting End User Outlook

  • Pharmaceutical & Biotechnology Companies

  • Research Organizations & Academic Institutes

3D Bioprinting Regional Outlook

  • North America

    • US

    • Canada

  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe

  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Australia

    • Rest of Asia-Pacific

  • Rest of the World

    • Middle East

    • Africa

    • Latin America

Report Attribute/Metric Details
Market Size 2023 USD 2.49 billion
Market Size 2024 USD 2.87 billion
Market Size 2032 USD 9.41 billion
Compound Annual Growth Rate (CAGR) 15.98% (2024-2032)
Base Year 2023
Market Forecast Period 2024-2032
Historical Data 2018 - 2022
Market Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends
Segments Covered Technology, Material, Application, End-user, and Region
Geographies Covered North America, Europe, Asia Pacific, and Rest of the World
Countries Covered The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled REGENHU Ltd. (Switzerland), Nano3D Biosciences Inc. (U.S.), FUJIFILM Wako Automation Corporation (U.S.), Organovo Holdings Inc. (U.S.), Allevi (U.S.), Regenovo Biotechnology Co. Ltd. (China), Stratasys Ltd. (U.S.), Aspect Biosystems Ltd. (Canada), Poietis (France), EnvisionTEC GmbH (Germany), Cellink AB (Sweden), Cyfuse Biomedical K.K. (Japan)
Key Market Opportunities Growing application of 3D printing in cosmetics
Key Market Dynamics Growing Demand for Organ Transplantation

Frequently Asked Questions (FAQ) :

The global 3D Bioprinting market size was valued at USD 2.49 Billion in 2023.

The global market is projected to grow at a CAGR of 15.98% during the forecast period, 2024-2032.

North America had the largest share in the global market

The key players in the market are REGENHU Ltd. (Switzerland), Nano3D Biosciences Inc. (U.S.), FUJIFILM Wako Automation Corporation (U.S.), Organovo Holdings Inc. (U.S.), Allevi (U.S.).

The Inkjet 3D Bioprinting category dominated the market in 2022.

The Research Applications had the largest share in the global market.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.